Choate Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Hold |
15,352
| – | – | 0.04% | 143 |
|
|
2025
Q1 | $1.96M | Hold |
15,352
| – | – | 0.05% | 135 |
|
|
2024
Q4 | $2.03M | Sell |
15,352
-250
| -2% | -$33.1K | 0.05% | 135 |
|
|
2024
Q3 | $2.27M | Hold |
15,602
| – | – | 0.06% | 130 |
|
|
2024
Q2 | $2.14M | Hold |
15,602
| – | – | 0.06% | 131 |
|
|
2024
Q1 | $2.14M | Buy |
+15,602
| New | +$2.14M | 0.06% | 138 |
|
|
2023
Q4 | – | Sell |
-606
| Closed | -$74.1K | – | 401 |
|
|
2023
Q3 | $74.1K | Sell |
606
-600
| -50% | -$73.4K | ﹤0.01% | 383 |
|
|
2023
Q2 | $153K | Hold |
1,206
| – | – | 0.01% | 292 |
|
|
2023
Q1 | $156K | Hold |
1,206
| – | – | 0.01% | 265 |
|
|
2022
Q4 | $158K | Hold |
1,206
| – | – | 0.01% | 272 |
|
|
2022
Q3 | $141K | Sell |
1,206
-200
| -14% | -$23.4K | 0.01% | 247 |
|
|
2022
Q2 | $165K | Hold |
1,406
| – | – | 0.01% | 259 |
|
|
2022
Q1 | $183K | Sell |
1,406
-415
| -23% | -$54K | 0.01% | 293 |
|
|
2021
Q4 | $278K | Buy |
1,821
+921
| +102% | +$141K | 0.02% | 240 |
|
|
2021
Q3 | $146K | Hold |
900
| – | – | 0.01% | 260 |
|
|
2021
Q2 | $147K | Hold |
900
| – | – | 0.01% | 272 |
|
|
2021
Q1 | $136K | Hold |
900
| – | – | 0.01% | 257 |
|
|
2020
Q4 | $136K | Hold |
900
| – | – | 0.01% | 245 |
|
|
2020
Q3 | $122K | Buy |
+900
| New | +$122K | 0.01% | 245 |
|